{"id": "article-20123_0", "title": "Crigler-Najjar Syndrome -- Continuing Education Activity", "content": "Crigler-Najjar syndrome is a\u00a0congenital autosomal recessive inherited disorder that leads to nonhemolytic jaundice. This syndrome is caused by an absence (CN1) or profoundly decreased level (CN2) of the enzyme UDP-glucuronosyltransferase due to a genetic defect in the UGT1A1 gene. This condition results in hyperbilirubinemia that may present soon after birth. Severe forms of this disease can cause hyperbilirubinemia, which can potentially cause irreversible brain damage. Hence, prompt diagnosis and treatment are of utmost importance. This activity reviews the evaluation and management of Crigler-Najjar syndrome. This activity also highlights the interprofessional team's role in caring for newborns with this condition.", "contents": "Crigler-Najjar Syndrome -- Continuing Education Activity. Crigler-Najjar syndrome is a\u00a0congenital autosomal recessive inherited disorder that leads to nonhemolytic jaundice. This syndrome is caused by an absence (CN1) or profoundly decreased level (CN2) of the enzyme UDP-glucuronosyltransferase due to a genetic defect in the UGT1A1 gene. This condition results in hyperbilirubinemia that may present soon after birth. Severe forms of this disease can cause hyperbilirubinemia, which can potentially cause irreversible brain damage. Hence, prompt diagnosis and treatment are of utmost importance. This activity reviews the evaluation and management of Crigler-Najjar syndrome. This activity also highlights the interprofessional team's role in caring for newborns with this condition."}
{"id": "article-20123_1", "title": "Crigler-Najjar Syndrome -- Continuing Education Activity", "content": "Objectives: Identify Crigler-Najjar syndrome early in newborns presenting with persistent severe hyperbilirubinemia to facilitate prompt diagnosis and intervention. Screen newborns for risk factors associated with the syndrome, such as family history, to ensure timely detection. Apply appropriate therapeutic interventions, including phototherapy and liver transplantation, based on the identified type and severity of Crigler-Najjar syndrome. Collaborate with a multidisciplinary team, including genetic counselors, pediatric neurologists, and surgeons, to ensure comprehensive and coordinated care. Access free multiple choice questions on this topic.", "contents": "Crigler-Najjar Syndrome -- Continuing Education Activity. Objectives: Identify Crigler-Najjar syndrome early in newborns presenting with persistent severe hyperbilirubinemia to facilitate prompt diagnosis and intervention. Screen newborns for risk factors associated with the syndrome, such as family history, to ensure timely detection. Apply appropriate therapeutic interventions, including phototherapy and liver transplantation, based on the identified type and severity of Crigler-Najjar syndrome. Collaborate with a multidisciplinary team, including genetic counselors, pediatric neurologists, and surgeons, to ensure comprehensive and coordinated care. Access free multiple choice questions on this topic."}
{"id": "article-20123_2", "title": "Crigler-Najjar Syndrome -- Introduction", "content": "Crigler-Najjar syndrome is a rare autosomal recessive disorder causing hyperbilirubinemia in newborns. Bilirubin metabolism involves the uptake of bilirubin from circulation, intracellular storage, conjugation with glucuronic acid, and excretion into bile. Abnormalities in any of these processes lead to hyperbilirubinemia. Crigler-Najjar syndrome is characterized by the absence or decreased activity of UDP-glucuronosyltransferase (UGT), an enzyme required for glucuronidation of unconjugated bilirubin in the liver.\u00a0This deficiency is a significant cause of congenital nonhemolytic jaundice. The syndrome is\u00a0classified into\u00a02 types based on the level of\u00a0UGT activity:", "contents": "Crigler-Najjar Syndrome -- Introduction. Crigler-Najjar syndrome is a rare autosomal recessive disorder causing hyperbilirubinemia in newborns. Bilirubin metabolism involves the uptake of bilirubin from circulation, intracellular storage, conjugation with glucuronic acid, and excretion into bile. Abnormalities in any of these processes lead to hyperbilirubinemia. Crigler-Najjar syndrome is characterized by the absence or decreased activity of UDP-glucuronosyltransferase (UGT), an enzyme required for glucuronidation of unconjugated bilirubin in the liver.\u00a0This deficiency is a significant cause of congenital nonhemolytic jaundice. The syndrome is\u00a0classified into\u00a02 types based on the level of\u00a0UGT activity:"}
{"id": "article-20123_3", "title": "Crigler-Najjar Syndrome -- Introduction", "content": "Type 1: Characterized by\u00a0severe\u00a0symptoms\u00a0due to minimal or a complete\u00a0absence of enzyme activity, individuals with Crigler-Najjar syndrome type 1 (CN1) experience life-threatening and severe jaundice, requiring regular phototherapy\u00a0for treatment. Patients with\u00a0this form of the disease are at very high risk of developing neurological complications, including permanent damage such as kernicterus. The only cure for\u00a0CN1 syndrome is a liver transplant. Type 2: This form of Crigler-Najjar syndrome is characterized by\u00a0milder\u00a0symptoms resulting from\u00a0reduced enzyme activity. Individuals with Crigler-Najjar syndrome type 2 (CN2) experience intermittent jaundice\u00a0triggered by stress and typically manage the condition through conservative measures. Permanent neurological damage is rare in CN2, and the need for a liver transplant is infrequent.", "contents": "Crigler-Najjar Syndrome -- Introduction. Type 1: Characterized by\u00a0severe\u00a0symptoms\u00a0due to minimal or a complete\u00a0absence of enzyme activity, individuals with Crigler-Najjar syndrome type 1 (CN1) experience life-threatening and severe jaundice, requiring regular phototherapy\u00a0for treatment. Patients with\u00a0this form of the disease are at very high risk of developing neurological complications, including permanent damage such as kernicterus. The only cure for\u00a0CN1 syndrome is a liver transplant. Type 2: This form of Crigler-Najjar syndrome is characterized by\u00a0milder\u00a0symptoms resulting from\u00a0reduced enzyme activity. Individuals with Crigler-Najjar syndrome type 2 (CN2) experience intermittent jaundice\u00a0triggered by stress and typically manage the condition through conservative measures. Permanent neurological damage is rare in CN2, and the need for a liver transplant is infrequent."}
{"id": "article-20123_4", "title": "Crigler-Najjar Syndrome -- Etiology", "content": "Crigler-Najjar syndrome is caused by an absence or decreased level of the UGT enzyme due to a genetic defect in the bilirubin UDP-glucuronosyltransferase family 1, polypeptide A1 ( UGT1A1 ) gene. [1] In CN1, common mutations include deletions, alterations in intron splice donor and receptor sites, missense mutations, exon skipping, insertions, or the formation of a stop codon within the UGT1A1 gene leading to complete deficiency of the UGT enzyme. [2] Conversely,\u00a0CN2\u00a0results from a point mutation in the UGT1A1 gene, resulting in\u00a0reduced production of the UGT enzyme. [2] [3]", "contents": "Crigler-Najjar Syndrome -- Etiology. Crigler-Najjar syndrome is caused by an absence or decreased level of the UGT enzyme due to a genetic defect in the bilirubin UDP-glucuronosyltransferase family 1, polypeptide A1 ( UGT1A1 ) gene. [1] In CN1, common mutations include deletions, alterations in intron splice donor and receptor sites, missense mutations, exon skipping, insertions, or the formation of a stop codon within the UGT1A1 gene leading to complete deficiency of the UGT enzyme. [2] Conversely,\u00a0CN2\u00a0results from a point mutation in the UGT1A1 gene, resulting in\u00a0reduced production of the UGT enzyme. [2] [3]"}
{"id": "article-20123_5", "title": "Crigler-Najjar Syndrome -- Epidemiology", "content": "Crigler-Najjar syndrome is an exceptionally rare disease, with an incidence rate of 0.6 to 1 in 1 million newborns worldwide. [4] [5] Despite its rarity, Crigler-Najjar syndrome requires careful medical attention and specialized care due to the severe consequences associated with elevated bilirubin levels in affected individuals.", "contents": "Crigler-Najjar Syndrome -- Epidemiology. Crigler-Najjar syndrome is an exceptionally rare disease, with an incidence rate of 0.6 to 1 in 1 million newborns worldwide. [4] [5] Despite its rarity, Crigler-Najjar syndrome requires careful medical attention and specialized care due to the severe consequences associated with elevated bilirubin levels in affected individuals."}
{"id": "article-20123_6", "title": "Crigler-Najjar Syndrome -- Pathophysiology", "content": "Bilirubin is one of the\u00a0byproducts produced when erythrocytes break down. Newborns are particularly vulnerable\u00a0to hyperbilirubinemia\u00a0due to their higher hemoglobin concentration at birth and impaired bilirubin excretion processes.", "contents": "Crigler-Najjar Syndrome -- Pathophysiology. Bilirubin is one of the\u00a0byproducts produced when erythrocytes break down. Newborns are particularly vulnerable\u00a0to hyperbilirubinemia\u00a0due to their higher hemoglobin concentration at birth and impaired bilirubin excretion processes."}
{"id": "article-20123_7", "title": "Crigler-Najjar Syndrome -- Pathophysiology", "content": "Typically, when erythrocytes break down, bilirubin is in its unconjugated form. This unconjugated bilirubin circulates in the bloodstream and\u00a0enters hepatocytes, where the UGT enzyme conjugates the bilirubin, making the substance water\u00a0soluble. Once conjugated, the\u00a0bilirubin\u00a0is excreted into bile (see Image. Metabolic Pathway for Bilirubin in the Hepatocyte). In Crigler-Najjar syndrome, a genetic mutation reduces (in CN2) or eliminates (in CN1) this enzyme, leading to decreased or no conjugation and causing an excess\u00a0of unconjugated bilirubin. Due to\u00a0the reduced or absent conjugation and excretion, the\u00a0level of unconjugated bilirubin overwhelms the body's albumin. This\u00a0surplus\u00a0of indirect bilirubin accumulates in body tissues such as the skin, sclera, and brain. About 99% of bilirubin is typically bound to albumin, which cannot cross the blood-brain barrier. In contrast, free (unbound) unconjugated bilirubin easily crosses the blood-brain barrier, interacting with neural tissue. [6] This accumulation can lead to severe complications in individuals with Crigler-Najjar syndrome.", "contents": "Crigler-Najjar Syndrome -- Pathophysiology. Typically, when erythrocytes break down, bilirubin is in its unconjugated form. This unconjugated bilirubin circulates in the bloodstream and\u00a0enters hepatocytes, where the UGT enzyme conjugates the bilirubin, making the substance water\u00a0soluble. Once conjugated, the\u00a0bilirubin\u00a0is excreted into bile (see Image. Metabolic Pathway for Bilirubin in the Hepatocyte). In Crigler-Najjar syndrome, a genetic mutation reduces (in CN2) or eliminates (in CN1) this enzyme, leading to decreased or no conjugation and causing an excess\u00a0of unconjugated bilirubin. Due to\u00a0the reduced or absent conjugation and excretion, the\u00a0level of unconjugated bilirubin overwhelms the body's albumin. This\u00a0surplus\u00a0of indirect bilirubin accumulates in body tissues such as the skin, sclera, and brain. About 99% of bilirubin is typically bound to albumin, which cannot cross the blood-brain barrier. In contrast, free (unbound) unconjugated bilirubin easily crosses the blood-brain barrier, interacting with neural tissue. [6] This accumulation can lead to severe complications in individuals with Crigler-Najjar syndrome."}
{"id": "article-20123_8", "title": "Crigler-Najjar Syndrome -- Histopathology", "content": "Historically, hepatic histology in Crigler-Najjar syndrome was\u00a0believed to be normal. However, recent studies\u00a0have revealed\u00a0certain\u00a0pathological changes. Microscopically, bile plugs are occasionally observed within canaliculi\u00a0due to cholestasis. Additionally, Crigler-Najjar syndrome can\u00a0cause\u00a0hepatic parenchymal injury. A small study reported transplant patients\u00a0displaying significant fibrosis seen in the explants, indicating the presence of structural abnormalities in the liver tissue. [7] [8]", "contents": "Crigler-Najjar Syndrome -- Histopathology. Historically, hepatic histology in Crigler-Najjar syndrome was\u00a0believed to be normal. However, recent studies\u00a0have revealed\u00a0certain\u00a0pathological changes. Microscopically, bile plugs are occasionally observed within canaliculi\u00a0due to cholestasis. Additionally, Crigler-Najjar syndrome can\u00a0cause\u00a0hepatic parenchymal injury. A small study reported transplant patients\u00a0displaying significant fibrosis seen in the explants, indicating the presence of structural abnormalities in the liver tissue. [7] [8]"}
{"id": "article-20123_9", "title": "Crigler-Najjar Syndrome -- History and Physical", "content": "In CN1,\u00a0a newborn may\u00a0exhibit\u00a0jaundice, although its absence\u00a0does not rule out the disease. In infants born healthy, persistent jaundice\u00a0caused\u00a0by unconjugated bilirubin typically\u00a0appears\u00a0within a few days and rapidly worsens by the second week. Factors such as a family history of consanguinity, severe jaundice without\u00a0signs of hemolysis, relatives or family members\u00a0undergoing or having undergone\u00a0exchange transfusion therapy,\u00a0or a family history of liver diseases support the diagnosis. Unconjugated hyperbilirubinemia in\u00a0CN1 usually ranges from 20 to 25 mg/dL. However, cases with significantly elevated unconjugated bilirubin levels, reaching 50 mg/dL, have been reported.", "contents": "Crigler-Najjar Syndrome -- History and Physical. In CN1,\u00a0a newborn may\u00a0exhibit\u00a0jaundice, although its absence\u00a0does not rule out the disease. In infants born healthy, persistent jaundice\u00a0caused\u00a0by unconjugated bilirubin typically\u00a0appears\u00a0within a few days and rapidly worsens by the second week. Factors such as a family history of consanguinity, severe jaundice without\u00a0signs of hemolysis, relatives or family members\u00a0undergoing or having undergone\u00a0exchange transfusion therapy,\u00a0or a family history of liver diseases support the diagnosis. Unconjugated hyperbilirubinemia in\u00a0CN1 usually ranges from 20 to 25 mg/dL. However, cases with significantly elevated unconjugated bilirubin levels, reaching 50 mg/dL, have been reported."}
{"id": "article-20123_10", "title": "Crigler-Najjar Syndrome -- History and Physical", "content": "During physical\u00a0examination, jaundice is apparent, characterized by yellowish skin and sclera. Stool color\u00a0remains normal;\u00a0however, there is\u00a0reduced excretion of fecal urobilinogen due to\u00a0markedly\u00a0decreased bilirubin conjugation.\u00a0Besides\u00a0jaundice, there are no abnormal findings in both types, and no signs of liver disease are observed. Older children\u00a0may exhibit scratch marks on the body due to pruritus. In\u00a0certain\u00a0instances, progressive liver dysfunction\u00a0and\u00a0additional\u00a0toxicities can cause hepatosplenomegaly.", "contents": "Crigler-Najjar Syndrome -- History and Physical. During physical\u00a0examination, jaundice is apparent, characterized by yellowish skin and sclera. Stool color\u00a0remains normal;\u00a0however, there is\u00a0reduced excretion of fecal urobilinogen due to\u00a0markedly\u00a0decreased bilirubin conjugation.\u00a0Besides\u00a0jaundice, there are no abnormal findings in both types, and no signs of liver disease are observed. Older children\u00a0may exhibit scratch marks on the body due to pruritus. In\u00a0certain\u00a0instances, progressive liver dysfunction\u00a0and\u00a0additional\u00a0toxicities can cause hepatosplenomegaly."}
{"id": "article-20123_11", "title": "Crigler-Najjar Syndrome -- History and Physical", "content": "Neurological symptoms in Crigler-Najjar syndrome arise from the toxic effects of bilirubin on the basal ganglia and brainstem nuclei for oculomotor and auditory functions. Acute bilirubin encephalopathy (ABE) initially\u00a0manifests\u00a0as sleepiness, mild to moderate hypotonia, and a high-pitched cry. Persistence of elevated bilirubin levels leads to the progression of ABE with symptoms such as fever, lethargy, poor suck, irritability, and hypertonia resulting in\u00a0retrocollis and opisthotonus. Advanced ABE can\u00a0involve\u00a0seizures, apnea, and a semi-comatose or comatose state. Respiratory failure or seizures can lead to fatal outcomes. Brainstem auditory-evoked responses (BAER) help detect\u00a0acute neurological dysfunction. [9]", "contents": "Crigler-Najjar Syndrome -- History and Physical. Neurological symptoms in Crigler-Najjar syndrome arise from the toxic effects of bilirubin on the basal ganglia and brainstem nuclei for oculomotor and auditory functions. Acute bilirubin encephalopathy (ABE) initially\u00a0manifests\u00a0as sleepiness, mild to moderate hypotonia, and a high-pitched cry. Persistence of elevated bilirubin levels leads to the progression of ABE with symptoms such as fever, lethargy, poor suck, irritability, and hypertonia resulting in\u00a0retrocollis and opisthotonus. Advanced ABE can\u00a0involve\u00a0seizures, apnea, and a semi-comatose or comatose state. Respiratory failure or seizures can lead to fatal outcomes. Brainstem auditory-evoked responses (BAER) help detect\u00a0acute neurological dysfunction. [9]"}
{"id": "article-20123_12", "title": "Crigler-Najjar Syndrome -- History and Physical", "content": "Chronic bilirubin encephalopathy (CBE),\u00a0also known as kernicterus, becomes apparent within the first year of life. Choreoathetoid cerebral palsy, sensorineural hearing loss, gaze abnormalities, and enamel hypoplasia characterize CBE. Generally, cognitive function remains unaffected. In instances of CBE, magnetic resonance imaging (MRI) of the brain reveals alterations in the cerebellum, hippocampus, and brainstem. [10] [11]", "contents": "Crigler-Najjar Syndrome -- History and Physical. Chronic bilirubin encephalopathy (CBE),\u00a0also known as kernicterus, becomes apparent within the first year of life. Choreoathetoid cerebral palsy, sensorineural hearing loss, gaze abnormalities, and enamel hypoplasia characterize CBE. Generally, cognitive function remains unaffected. In instances of CBE, magnetic resonance imaging (MRI) of the brain reveals alterations in the cerebellum, hippocampus, and brainstem. [10] [11]"}
{"id": "article-20123_13", "title": "Crigler-Najjar Syndrome -- History and Physical", "content": "CN2 is a milder condition characterized by fewer and less severe clinical symptoms. Patients with this syndrome may require periodic assessments to monitor bilirubin levels and liver function, aiding in the management and early detection of potential complications.", "contents": "Crigler-Najjar Syndrome -- History and Physical. CN2 is a milder condition characterized by fewer and less severe clinical symptoms. Patients with this syndrome may require periodic assessments to monitor bilirubin levels and liver function, aiding in the management and early detection of potential complications."}
{"id": "article-20123_14", "title": "Crigler-Najjar Syndrome -- Evaluation", "content": "Patients\u00a0suspected\u00a0of\u00a0having Crigler-Najjar syndrome should undergo serum unconjugated bilirubin level testing, with significantly higher levels seen\u00a0in\u00a0CN1 than CN2. In CN1, the unconjugated bilirubin is between 2 and 25 mg/dL, but severe cases can reach 50 mg/dL.\u00a0CN2 cases typically exhibit\u00a0levels below 20 mg/dL.", "contents": "Crigler-Najjar Syndrome -- Evaluation. Patients\u00a0suspected\u00a0of\u00a0having Crigler-Najjar syndrome should undergo serum unconjugated bilirubin level testing, with significantly higher levels seen\u00a0in\u00a0CN1 than CN2. In CN1, the unconjugated bilirubin is between 2 and 25 mg/dL, but severe cases can reach 50 mg/dL.\u00a0CN2 cases typically exhibit\u00a0levels below 20 mg/dL."}
{"id": "article-20123_15", "title": "Crigler-Najjar Syndrome -- Evaluation", "content": "Historically, collection for bile analysis involved procedures like\u00a0upper gastrointestinal endoscopy or duodenal catheterization, followed by high-performance liquid chromatography (HPLC). However,\u00a0modern diagnoses primarily rely on\u00a0genetic testing methods. [12] The administration of phenobarbital for\u00a02\u00a0weeks has decreased serum bilirubin concentration in most patients with CN2. [13] Notably, CN1\u00a0does not respond to phenobarbital treatment.", "contents": "Crigler-Najjar Syndrome -- Evaluation. Historically, collection for bile analysis involved procedures like\u00a0upper gastrointestinal endoscopy or duodenal catheterization, followed by high-performance liquid chromatography (HPLC). However,\u00a0modern diagnoses primarily rely on\u00a0genetic testing methods. [12] The administration of phenobarbital for\u00a02\u00a0weeks has decreased serum bilirubin concentration in most patients with CN2. [13] Notably, CN1\u00a0does not respond to phenobarbital treatment."}
{"id": "article-20123_16", "title": "Crigler-Najjar Syndrome -- Evaluation", "content": "Genetic analysis can be performed\u00a0on DNA extracted from peripheral blood leukocytes, buccal scrapings,\u00a0and\u00a0other tissues,\u00a0enabling\u00a0the identification of\u00a0mutations in the gene encoding the UGT enzyme. Prenatal diagnosis is possible with genetic analysis of chorionic villus samples or amniotic cells aspirated\u00a0from amniotic fluid aspirates. Additionally, diffusion tensor brain imaging may help\u00a0detect microstructural gray and white matter changes in CN1 syndrome. [14] Liver biopsy and histopathologic analysis can help to evaluate liver cirrhosis in established cases of hepatosplenomegaly.", "contents": "Crigler-Najjar Syndrome -- Evaluation. Genetic analysis can be performed\u00a0on DNA extracted from peripheral blood leukocytes, buccal scrapings,\u00a0and\u00a0other tissues,\u00a0enabling\u00a0the identification of\u00a0mutations in the gene encoding the UGT enzyme. Prenatal diagnosis is possible with genetic analysis of chorionic villus samples or amniotic cells aspirated\u00a0from amniotic fluid aspirates. Additionally, diffusion tensor brain imaging may help\u00a0detect microstructural gray and white matter changes in CN1 syndrome. [14] Liver biopsy and histopathologic analysis can help to evaluate liver cirrhosis in established cases of hepatosplenomegaly."}
{"id": "article-20123_17", "title": "Crigler-Najjar Syndrome -- Treatment / Management", "content": "The\u00a0primary\u00a0treatment\u00a0goal\u00a0focuses\u00a0on\u00a0lowering unconjugated bilirubin levels\u00a0through phototherapy and plasmapheresis.\u00a0Although most patients survive beyond puberty without significant brain damage, they are at risk of developing kernicterus later in life.\u00a0Presently, liver transplantation stands as the sole curative option for CN1. [15]", "contents": "Crigler-Najjar Syndrome -- Treatment / Management. The\u00a0primary\u00a0treatment\u00a0goal\u00a0focuses\u00a0on\u00a0lowering unconjugated bilirubin levels\u00a0through phototherapy and plasmapheresis.\u00a0Although most patients survive beyond puberty without significant brain damage, they are at risk of developing kernicterus later in life.\u00a0Presently, liver transplantation stands as the sole curative option for CN1. [15]"}
{"id": "article-20123_18", "title": "Crigler-Najjar Syndrome -- Treatment / Management -- Phototherapy", "content": "The\u00a0primary\u00a0treatment\u00a0approach for\u00a0CN1 involves intensive, often daily, phototherapy. Phototherapy is often part of the treatment of neonatal hyperbilirubinemia. [16] Intensive phototherapy\u00a0proves\u00a0more effective than conventional approaches as it\u00a0leads to a quicker response, shortens the treatment duration, and minimizes late complications. [17] Phototherapy is less effective in older children and adults due to thicker skin, increased skin pigmentation, and\u00a0smaller body surface area in proportion to body mass. [15]", "contents": "Crigler-Najjar Syndrome -- Treatment / Management -- Phototherapy. The\u00a0primary\u00a0treatment\u00a0approach for\u00a0CN1 involves intensive, often daily, phototherapy. Phototherapy is often part of the treatment of neonatal hyperbilirubinemia. [16] Intensive phototherapy\u00a0proves\u00a0more effective than conventional approaches as it\u00a0leads to a quicker response, shortens the treatment duration, and minimizes late complications. [17] Phototherapy is less effective in older children and adults due to thicker skin, increased skin pigmentation, and\u00a0smaller body surface area in proportion to body mass. [15]"}
{"id": "article-20123_19", "title": "Crigler-Najjar Syndrome -- Treatment / Management -- Plasmapheresis", "content": "Plasmapheresis is the most effective\u00a0method\u00a0for removing excess unconjugated bilirubin from the blood during severe hyperbilirubinemia crisis.\u00a0This process\u00a0involves extracting blood from the patient, separating blood cells from plasma, and replacing the plasma with donor plasma. The patient's blood is then transfused back after this exchange. Bilirubin tightly\u00a0binds to albumin; therefore,\u00a0removing\u00a0albumin during\u00a0plasmapheresis\u00a0effectively reduces\u00a0bilirubin levels in the bloodstream. Plasmapheresis serves as a targeted approach to eliminating unwanted substances from the blood.", "contents": "Crigler-Najjar Syndrome -- Treatment / Management -- Plasmapheresis. Plasmapheresis is the most effective\u00a0method\u00a0for removing excess unconjugated bilirubin from the blood during severe hyperbilirubinemia crisis.\u00a0This process\u00a0involves extracting blood from the patient, separating blood cells from plasma, and replacing the plasma with donor plasma. The patient's blood is then transfused back after this exchange. Bilirubin tightly\u00a0binds to albumin; therefore,\u00a0removing\u00a0albumin during\u00a0plasmapheresis\u00a0effectively reduces\u00a0bilirubin levels in the bloodstream. Plasmapheresis serves as a targeted approach to eliminating unwanted substances from the blood."}
{"id": "article-20123_20", "title": "Crigler-Najjar Syndrome -- Treatment / Management -- Orlistat", "content": "Orlistat, a\u00a0lipase inhibitor, demonstrates enhanced efficiency\u00a0when used alongside\u00a0calcium phosphate.\u00a0The theory behind its mechanism suggests that it\u00a0captures unconjugated intestinal bilirubin and\u00a0aids\u00a0in its excretion, correlating with the amount of fat\u00a0expelled in stools. [18]", "contents": "Crigler-Najjar Syndrome -- Treatment / Management -- Orlistat. Orlistat, a\u00a0lipase inhibitor, demonstrates enhanced efficiency\u00a0when used alongside\u00a0calcium phosphate.\u00a0The theory behind its mechanism suggests that it\u00a0captures unconjugated intestinal bilirubin and\u00a0aids\u00a0in its excretion, correlating with the amount of fat\u00a0expelled in stools. [18]"}
{"id": "article-20123_21", "title": "Crigler-Najjar Syndrome -- Treatment / Management -- Calcium Phosphate Supplementation", "content": "A randomized controlled study of patients with CN1, who have undergone phototherapy and were supplemented with calcium phosphate, demonstrated an 18% reduction in serum bilirubin levels. This indicates that calcium phosphate may trap photoproducts excreted in the bile. [19] Supporting this, animal studies\u00a0with rats have shown decreased serum bilirubin concentrations\u00a0following oral calcium phosphate supplementation, likely\u00a0due to the\u00a0trapping of unconjugated bilirubin in the gut. [20]", "contents": "Crigler-Najjar Syndrome -- Treatment / Management -- Calcium Phosphate Supplementation. A randomized controlled study of patients with CN1, who have undergone phototherapy and were supplemented with calcium phosphate, demonstrated an 18% reduction in serum bilirubin levels. This indicates that calcium phosphate may trap photoproducts excreted in the bile. [19] Supporting this, animal studies\u00a0with rats have shown decreased serum bilirubin concentrations\u00a0following oral calcium phosphate supplementation, likely\u00a0due to the\u00a0trapping of unconjugated bilirubin in the gut. [20]"}
{"id": "article-20123_22", "title": "Crigler-Najjar Syndrome -- Treatment / Management -- Liver Transplantation", "content": "Liver transplantation stands as the sole\u00a0therapeutic and definitive treatment method for CN1. The transplanted liver\u00a0possesses\u00a0a healthy UGT enzyme, enabling effective bilirubin conjugation and rapidly\u00a0lowering serum bilirubin levels. Prophylactic liver transplantation is\u00a0highly recommended\u00a0to prevent kernicterus, as once\u00a0this condition develops, it may not be\u00a0reversible. [21]", "contents": "Crigler-Najjar Syndrome -- Treatment / Management -- Liver Transplantation. Liver transplantation stands as the sole\u00a0therapeutic and definitive treatment method for CN1. The transplanted liver\u00a0possesses\u00a0a healthy UGT enzyme, enabling effective bilirubin conjugation and rapidly\u00a0lowering serum bilirubin levels. Prophylactic liver transplantation is\u00a0highly recommended\u00a0to prevent kernicterus, as once\u00a0this condition develops, it may not be\u00a0reversible. [21]"}
{"id": "article-20123_23", "title": "Crigler-Najjar Syndrome -- Treatment / Management -- Hepatocyte Transplantation", "content": "Hepatocyte transplantation is a promising alternative to liver transplantation.\u00a0During this procedure,\u00a0healthy hepatocytes are infused into the portal vein or the peritoneal space. This method\u00a0offers a temporary reduction of\u00a0serum bilirubin levels, with published reports\u00a0showing a 50% reduction in bilirubin levels. [22] [23]", "contents": "Crigler-Najjar Syndrome -- Treatment / Management -- Hepatocyte Transplantation. Hepatocyte transplantation is a promising alternative to liver transplantation.\u00a0During this procedure,\u00a0healthy hepatocytes are infused into the portal vein or the peritoneal space. This method\u00a0offers a temporary reduction of\u00a0serum bilirubin levels, with published reports\u00a0showing a 50% reduction in bilirubin levels. [22] [23]"}
{"id": "article-20123_24", "title": "Crigler-Najjar Syndrome -- Treatment / Management -- Gene Therapy", "content": "The potential cure for the genetic defect lies in introducing a normal UGT1A1 gene, achieved through ex vivo gene transduction, where the gene is\u00a0introduced into cultured hepatocytes or\u00a0vector-mediated gene delivery methods. Adenovirus is the most effective vector for transferring genes to liver cells. [4] Currently, plans for conducting clinical trials in humans are underway, marking significant progress in pursuing a cure.", "contents": "Crigler-Najjar Syndrome -- Treatment / Management -- Gene Therapy. The potential cure for the genetic defect lies in introducing a normal UGT1A1 gene, achieved through ex vivo gene transduction, where the gene is\u00a0introduced into cultured hepatocytes or\u00a0vector-mediated gene delivery methods. Adenovirus is the most effective vector for transferring genes to liver cells. [4] Currently, plans for conducting clinical trials in humans are underway, marking significant progress in pursuing a cure."}
{"id": "article-20123_25", "title": "Crigler-Najjar Syndrome -- Treatment / Management -- Inhibition of Bilirubin Production", "content": "A single dose of heme oxygenase inhibitors, like tin-protoporphyrin or tin-mesoporphyrin, administered to neonates has demonstrated a 76% decrease in bilirubin\u00a0levels, eliminating the\u00a0necessity\u00a0for phototherapy. [24] [25] However, in adults, this effect is short-lived and therefore reserved for acute emergencies.", "contents": "Crigler-Najjar Syndrome -- Treatment / Management -- Inhibition of Bilirubin Production. A single dose of heme oxygenase inhibitors, like tin-protoporphyrin or tin-mesoporphyrin, administered to neonates has demonstrated a 76% decrease in bilirubin\u00a0levels, eliminating the\u00a0necessity\u00a0for phototherapy. [24] [25] However, in adults, this effect is short-lived and therefore reserved for acute emergencies."}
{"id": "article-20123_26", "title": "Crigler-Najjar Syndrome -- Treatment / Management -- Phenobarbitol", "content": "Patients with Crigler-Najjar syndrome usually do not require treatment with phenobarbital. However, patients\u00a0experiencing jaundice\u00a0that\u00a0impacts their quality of life may receive phenobarbital therapy, which works by inducing the\u00a0remaining UGT activity. Notably, phenobarbitol has no role in CN1, but it can reduce the serum bilirubin level by 25% in patients with CN2. [13] There have been documented cases\u00a0where pregnant women with\u00a0CN2\u00a0were\u00a0successfully treated with phenobarbital during pregnancy. [26] [27]", "contents": "Crigler-Najjar Syndrome -- Treatment / Management -- Phenobarbitol. Patients with Crigler-Najjar syndrome usually do not require treatment with phenobarbital. However, patients\u00a0experiencing jaundice\u00a0that\u00a0impacts their quality of life may receive phenobarbital therapy, which works by inducing the\u00a0remaining UGT activity. Notably, phenobarbitol has no role in CN1, but it can reduce the serum bilirubin level by 25% in patients with CN2. [13] There have been documented cases\u00a0where pregnant women with\u00a0CN2\u00a0were\u00a0successfully treated with phenobarbital during pregnancy. [26] [27]"}
{"id": "article-20123_27", "title": "Crigler-Najjar Syndrome -- Differential Diagnosis", "content": "Distinguishing Crigler-Najjar syndrome from other causes\u00a0of unconjugated hyperbilirubinemia\u00a0relies\u00a0on\u00a0evaluating the bilirubin levels and the duration of hyperbilirubinemia. Additionally, classification is based on\u00a0underlying causes and specific conditions.", "contents": "Crigler-Najjar Syndrome -- Differential Diagnosis. Distinguishing Crigler-Najjar syndrome from other causes\u00a0of unconjugated hyperbilirubinemia\u00a0relies\u00a0on\u00a0evaluating the bilirubin levels and the duration of hyperbilirubinemia. Additionally, classification is based on\u00a0underlying causes and specific conditions."}
{"id": "article-20123_28", "title": "Crigler-Najjar Syndrome -- Differential Diagnosis -- Increased Production", "content": "Hemolysis:\u00a0Conditions like\u00a0sickle cell disease, hereditary spherocytosis, and Rh isoimmunization can lead to hemolysis, where the bilirubin level\u00a0typically remains below\u00a06 to 8 mg/dL in exclusive hemolysis cases in newborns. Rh isoimmunization,\u00a0 incompatible fetal and maternal red cells, can cause pronounced jaundice but is always associated with signs of active hemolysis. Ineffective erythropoiesis: Diseases related to ineffective erythropoiesis, such as thalassemia, pernicious anemia, iron deficiency anemia, and lead poisoning, can result in a marked increase in bilirubin levels. Gastrointestinal (GI) bleeding and hematoma: GI bleeding and hematomas contribute to hyperbilirubinemia. One case report with hematochezia and jaundice reported polyp formation was responsible for rectal bleeding related to biliary abnormalities. [28] Conditions like hemobilia, where GI bleeding leads to resorption of blood and an increase in unconjugated bilirubin concentration, can cause jaundice. [29]", "contents": "Crigler-Najjar Syndrome -- Differential Diagnosis -- Increased Production. Hemolysis:\u00a0Conditions like\u00a0sickle cell disease, hereditary spherocytosis, and Rh isoimmunization can lead to hemolysis, where the bilirubin level\u00a0typically remains below\u00a06 to 8 mg/dL in exclusive hemolysis cases in newborns. Rh isoimmunization,\u00a0 incompatible fetal and maternal red cells, can cause pronounced jaundice but is always associated with signs of active hemolysis. Ineffective erythropoiesis: Diseases related to ineffective erythropoiesis, such as thalassemia, pernicious anemia, iron deficiency anemia, and lead poisoning, can result in a marked increase in bilirubin levels. Gastrointestinal (GI) bleeding and hematoma: GI bleeding and hematomas contribute to hyperbilirubinemia. One case report with hematochezia and jaundice reported polyp formation was responsible for rectal bleeding related to biliary abnormalities. [28] Conditions like hemobilia, where GI bleeding leads to resorption of blood and an increase in unconjugated bilirubin concentration, can cause jaundice. [29]"}
{"id": "article-20123_29", "title": "Crigler-Najjar Syndrome -- Differential Diagnosis -- Decreased Clearance", "content": "Liver diseases:\u00a0Any\u00a0liver disease affecting the conjugation\u00a0and efficient excretion of bilirubin can lead to jaundice. Drug-induced: Liver injury caused by drugs such as\u00a0amoxicillin, cefazolin, nitrofurantoin, chloramphenicol, and isoniazid can impair the liver's conjugating capacity, resulting in hyperbilirubinemia. [30] [31]", "contents": "Crigler-Najjar Syndrome -- Differential Diagnosis -- Decreased Clearance. Liver diseases:\u00a0Any\u00a0liver disease affecting the conjugation\u00a0and efficient excretion of bilirubin can lead to jaundice. Drug-induced: Liver injury caused by drugs such as\u00a0amoxicillin, cefazolin, nitrofurantoin, chloramphenicol, and isoniazid can impair the liver's conjugating capacity, resulting in hyperbilirubinemia. [30] [31]"}
{"id": "article-20123_30", "title": "Crigler-Najjar Syndrome -- Differential Diagnosis -- Genetic Conditions", "content": "Gilbert syndrome: This common inherited hyperbilirubinemia affects the UGT1A1 gene's promoter region, reducing normal protein production.\u00a0As the UGT enzyme deficiency is not severe, Gilbert syndrome has benign manifestations, distinguishing it from CN1. Lucey-Driscoll syndrome:\u00a0Also known as transient familial hyperbilirubinemia, it is caused by compounds in the mother's and baby's blood that block the bilirubin breakdown. Neonatal jaundice and prematurity: Physiologic jaundice in newborns can result from various factors like liver dysfunction, infection, hypothyroidism, and metabolic disorders. Premature infants often have higher bilirubin levels due to immaturity. Physiologic jaundice usually resolves within the first\u00a010 days of life.", "contents": "Crigler-Najjar Syndrome -- Differential Diagnosis -- Genetic Conditions. Gilbert syndrome: This common inherited hyperbilirubinemia affects the UGT1A1 gene's promoter region, reducing normal protein production.\u00a0As the UGT enzyme deficiency is not severe, Gilbert syndrome has benign manifestations, distinguishing it from CN1. Lucey-Driscoll syndrome:\u00a0Also known as transient familial hyperbilirubinemia, it is caused by compounds in the mother's and baby's blood that block the bilirubin breakdown. Neonatal jaundice and prematurity: Physiologic jaundice in newborns can result from various factors like liver dysfunction, infection, hypothyroidism, and metabolic disorders. Premature infants often have higher bilirubin levels due to immaturity. Physiologic jaundice usually resolves within the first\u00a010 days of life."}
{"id": "article-20123_31", "title": "Crigler-Najjar Syndrome -- Differential Diagnosis -- Special Cases", "content": "Breast milk jaundice: Some breastfeeding neonates\u00a0experience elevated bilirubin within\u00a02 weeks of birth,\u00a0lasting\u00a03 to 12 weeks, often longer than physiologic jaundice. Rotor syndrome and Dubin-Johnson syndrome: Rare inherited disorders causing jaundice with high levels of conjugated bilirubin. Rotor syndrome results\u00a0from alterations in\u00a02 genes, SLCO1B1 and SLCO1B3 , while Dubin-Johnson syndrome results\u00a0from ABCC2 gene mutations.", "contents": "Crigler-Najjar Syndrome -- Differential Diagnosis -- Special Cases. Breast milk jaundice: Some breastfeeding neonates\u00a0experience elevated bilirubin within\u00a02 weeks of birth,\u00a0lasting\u00a03 to 12 weeks, often longer than physiologic jaundice. Rotor syndrome and Dubin-Johnson syndrome: Rare inherited disorders causing jaundice with high levels of conjugated bilirubin. Rotor syndrome results\u00a0from alterations in\u00a02 genes, SLCO1B1 and SLCO1B3 , while Dubin-Johnson syndrome results\u00a0from ABCC2 gene mutations."}
{"id": "article-20123_32", "title": "Crigler-Najjar Syndrome -- Prognosis", "content": "CN1\u00a0has a poor prognosis, often necessitating emergent intervention during hyperbilirubinemia crises. Once kernicterus develops, this syndrome tends to be irreversible. In contrast, CN2,\u00a0due to residual UGT enzyme activity,\u00a0presents with mild symptoms or can even be asymptomatic.\u00a0Studies report varying incidences of permanent neurological impairment in patients with CN1, ranging up to 30% of cases. [15] [32] [33]", "contents": "Crigler-Najjar Syndrome -- Prognosis. CN1\u00a0has a poor prognosis, often necessitating emergent intervention during hyperbilirubinemia crises. Once kernicterus develops, this syndrome tends to be irreversible. In contrast, CN2,\u00a0due to residual UGT enzyme activity,\u00a0presents with mild symptoms or can even be asymptomatic.\u00a0Studies report varying incidences of permanent neurological impairment in patients with CN1, ranging up to 30% of cases. [15] [32] [33]"}
{"id": "article-20123_33", "title": "Crigler-Najjar Syndrome -- Complications", "content": "An outline of potential complications for Crigler-Najjar syndrome are as follows: Kernicterus: Unconjugated bilirubin, being fat-soluble, can\u00a0penetrate\u00a0cell membranes. At high serum levels,\u00a0typically above 25 mg/dL, unconjugated bilirubin can cross the blood-brain barrier, causing neurotoxicity. While more commonly seen in patients with CN1, patients with CN2 are\u00a0also at risk, especially in cases where\u00a0serum bilirubin levels may rise to 40 mg/dL. Commonly affected areas of the brain include the hippocampus, geniculate bodies, basal ganglia, and nerve nuclei. [34] Early diagnosis and treatment are crucial to prevent kernicterus. Chronic jaundice: Persistent disease and\u00a0delayed diagnosis lead to chronic jaundice. Bilirubin levels\u00a0progressively increase due to limited excretion, leading to widespread deposition throughout the body at later stages.", "contents": "Crigler-Najjar Syndrome -- Complications. An outline of potential complications for Crigler-Najjar syndrome are as follows: Kernicterus: Unconjugated bilirubin, being fat-soluble, can\u00a0penetrate\u00a0cell membranes. At high serum levels,\u00a0typically above 25 mg/dL, unconjugated bilirubin can cross the blood-brain barrier, causing neurotoxicity. While more commonly seen in patients with CN1, patients with CN2 are\u00a0also at risk, especially in cases where\u00a0serum bilirubin levels may rise to 40 mg/dL. Commonly affected areas of the brain include the hippocampus, geniculate bodies, basal ganglia, and nerve nuclei. [34] Early diagnosis and treatment are crucial to prevent kernicterus. Chronic jaundice: Persistent disease and\u00a0delayed diagnosis lead to chronic jaundice. Bilirubin levels\u00a0progressively increase due to limited excretion, leading to widespread deposition throughout the body at later stages."}
{"id": "article-20123_34", "title": "Crigler-Najjar Syndrome -- Complications", "content": "Cholelithiasis: Increased unconjugated bilirubin concentration can lead to gallstone formation, usually appearing later in life due to the gradual accumulation of bilirubin. Liver cirrhosis: Liver cirrhosis develops over a\u00a0prolonged\u00a0period. Most children born with Crigler-Najjar\u00a0syndrome have healthy livers initially.\u00a0The exact mechanism of liver cirrhosis remains unknown. However, it may result from chronic biliary obstruction secondary to cholelithiasis, toxicity from drugs primarily metabolized in the liver, toxicity from phototherapy, and heme degradation products. [35]", "contents": "Crigler-Najjar Syndrome -- Complications. Cholelithiasis: Increased unconjugated bilirubin concentration can lead to gallstone formation, usually appearing later in life due to the gradual accumulation of bilirubin. Liver cirrhosis: Liver cirrhosis develops over a\u00a0prolonged\u00a0period. Most children born with Crigler-Najjar\u00a0syndrome have healthy livers initially.\u00a0The exact mechanism of liver cirrhosis remains unknown. However, it may result from chronic biliary obstruction secondary to cholelithiasis, toxicity from drugs primarily metabolized in the liver, toxicity from phototherapy, and heme degradation products. [35]"}
{"id": "article-20123_35", "title": "Crigler-Najjar Syndrome -- Consultations", "content": "Consultations for Crigler-Najjar syndrome typically involve a multidisciplinary team of healthcare professionals, including neonatology, pediatric gastroenterology and hepatology, pediatric genetics, genetic counselor, neurologist, and nutritionist or dietitian. The patient's pediatrician or neonatologist is crucial for the initial diagnosis and monitoring of the child's growth and overall health.", "contents": "Crigler-Najjar Syndrome -- Consultations. Consultations for Crigler-Najjar syndrome typically involve a multidisciplinary team of healthcare professionals, including neonatology, pediatric gastroenterology and hepatology, pediatric genetics, genetic counselor, neurologist, and nutritionist or dietitian. The patient's pediatrician or neonatologist is crucial for the initial diagnosis and monitoring of the child's growth and overall health."}
{"id": "article-20123_36", "title": "Crigler-Najjar Syndrome -- Consultations", "content": "Referral to a pediatric gastroenterologist or hepatologist may be necessary for specialized care for liver diseases, including monitoring for liver-related complications. They also play a crucial role in assessing the eligibility for liver transplantation, coordinating the transplant evaluation process, and providing post-transplant care, ensuring comprehensive management of liver-related challenges in Crigler-Najjar syndrome patients.", "contents": "Crigler-Najjar Syndrome -- Consultations. Referral to a pediatric gastroenterologist or hepatologist may be necessary for specialized care for liver diseases, including monitoring for liver-related complications. They also play a crucial role in assessing the eligibility for liver transplantation, coordinating the transplant evaluation process, and providing post-transplant care, ensuring comprehensive management of liver-related challenges in Crigler-Najjar syndrome patients."}
{"id": "article-20123_37", "title": "Crigler-Najjar Syndrome -- Consultations", "content": "The care team may also comprise a genetic counselor to help the family understand the genetic implications of the syndrome, provide information about inheritance patterns, and discuss the risk of passing the condition to future generations. If there are neurological complications or concerns, a neurologist may also be necessary. Nutritionists and dietitians can assist in developing specialized diet plans to manage the condtion,\u00a0ensuring adequate nutrition while minimizing the risk of bilirubin buildup.", "contents": "Crigler-Najjar Syndrome -- Consultations. The care team may also comprise a genetic counselor to help the family understand the genetic implications of the syndrome, provide information about inheritance patterns, and discuss the risk of passing the condition to future generations. If there are neurological complications or concerns, a neurologist may also be necessary. Nutritionists and dietitians can assist in developing specialized diet plans to manage the condtion,\u00a0ensuring adequate nutrition while minimizing the risk of bilirubin buildup."}
{"id": "article-20123_38", "title": "Crigler-Najjar Syndrome -- Deterrence and Patient Education", "content": "Crigler-Najjar syndrome leads to\u00a0an accumulation of bilirubin in the blood due to an abnormal gene inherited within families. The disease severity\u00a0varies between\u00a0its\u00a02 types, making differentiation crucial for appropriate interventions. Screening\u00a0close\u00a0relatives\u00a0is advisable. Tailored patient education, adapted to the parents' understanding, is essential. Detailed information about signs and symptoms\u00a0empowers\u00a0parents to facilitate early\u00a0diagnosis and treatment, preventing complications and\u00a0enhancing\u00a0outcomes. Additionally, educating parents about the\u00a0advantages and disadvantages of different tests and treatments is vital for making well-informed decisions.", "contents": "Crigler-Najjar Syndrome -- Deterrence and Patient Education. Crigler-Najjar syndrome leads to\u00a0an accumulation of bilirubin in the blood due to an abnormal gene inherited within families. The disease severity\u00a0varies between\u00a0its\u00a02 types, making differentiation crucial for appropriate interventions. Screening\u00a0close\u00a0relatives\u00a0is advisable. Tailored patient education, adapted to the parents' understanding, is essential. Detailed information about signs and symptoms\u00a0empowers\u00a0parents to facilitate early\u00a0diagnosis and treatment, preventing complications and\u00a0enhancing\u00a0outcomes. Additionally, educating parents about the\u00a0advantages and disadvantages of different tests and treatments is vital for making well-informed decisions."}
{"id": "article-20123_39", "title": "Crigler-Najjar Syndrome -- Enhancing Healthcare Team Outcomes", "content": "A collaborative interprofessional team, utilizing an evidence-based approach for initial diagnosis and\u00a0subsequent monitoring, is crucial in\u00a0Crigler-Najjar syndrome.\u00a0Early diagnosis and timely therapeutic\u00a0interventions,\u00a0facilitated by this team, can significantly improve outcomes by reducing the duration of treatments and preventing complications. Neonatologists, drawing on their clinical expertise, play a pivotal role in\u00a0diagnosing the condition. Pediatric gastroenterologists, medical geneticists, and histopathologists\u00a0further confirm the diagnosis.", "contents": "Crigler-Najjar Syndrome -- Enhancing Healthcare Team Outcomes. A collaborative interprofessional team, utilizing an evidence-based approach for initial diagnosis and\u00a0subsequent monitoring, is crucial in\u00a0Crigler-Najjar syndrome.\u00a0Early diagnosis and timely therapeutic\u00a0interventions,\u00a0facilitated by this team, can significantly improve outcomes by reducing the duration of treatments and preventing complications. Neonatologists, drawing on their clinical expertise, play a pivotal role in\u00a0diagnosing the condition. Pediatric gastroenterologists, medical geneticists, and histopathologists\u00a0further confirm the diagnosis."}
{"id": "article-20123_40", "title": "Crigler-Najjar Syndrome -- Enhancing Healthcare Team Outcomes", "content": "In cases complicated by kernicterus or early ABE, pediatric neurologists are instrumental in managing severity and\u00a0communicating prognosis details to parents. Pediatric surgeons contribute to curative treatment by liver transplantation. Hospitalized patients' outcomes are influenced by hospital protocols and the quality of care. While patients with\u00a0CN1 often await liver transplantation, effective management in a hospital setting is essential to prevent kernicterus. [33]", "contents": "Crigler-Najjar Syndrome -- Enhancing Healthcare Team Outcomes. In cases complicated by kernicterus or early ABE, pediatric neurologists are instrumental in managing severity and\u00a0communicating prognosis details to parents. Pediatric surgeons contribute to curative treatment by liver transplantation. Hospitalized patients' outcomes are influenced by hospital protocols and the quality of care. While patients with\u00a0CN1 often await liver transplantation, effective management in a hospital setting is essential to prevent kernicterus. [33]"}
{"id": "article-20123_41", "title": "Crigler-Najjar Syndrome -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Crigler-Najjar Syndrome -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}